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fibres that are long and curly (7). Amphibole forms of
asbestos may be of amosite, crocidolite or anthophyllite
types, and are shorter and straighter than serpentine
varieties. According to the Stanton Hypothesis,
amphibole fibres were originally believed to pose less
risk (4, 6), but these fibres were then linked to increased
rates of mesothelioma (8).
History of exposure
Dr. Montague Murray first recognized the negative
health effects of asbestos in 1899 (9).  However, dust
control legislation for mines was not enacted in North
America until 1971 (3).  In the intermediate years,
mining and use of asbestos increased dramatically by
120-fold, peaking upon the enaction of legislation in
1971, and decreasing exponentially until the present
(Figure 1). The current decreases in the rate of mining
are due to public health concerns and to the
progressively more restrictive standards placed upon
the level of asbestos dust allowed in mines, from 5
fibres/cm3 in 1971 (3) to 1 fibres/cm3 at present (10).
Although the global levels of asbestos mined have
decreased significantly, Canada continues to be one of
the world's leading producers. 2.4 x 105 tonnes were
mined in Canada in 2003 (11), which accounted for
much of the world's production of asbestos (12).   
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INTRODUCTION
This critical examination of the historical and current
health effects of exposure to asbestos will first focus on
a historical introduction to asbestos, and then assess the
risks of exposure, causes of health problems and
resulting health effects of exposure to asbestos.  Focus
is placed on assessing occupational health risks
associated with mining asbestos, with special emphasis
on differentiating between the health risks of different
types and lengths of asbestos fibres. The purpose of this
focus is to assess the validity of claims made by
policymakers and the Chrysotile Institute that the type
of asbestos mined in Canada is significantly safer than
other types of asbestos (1, 2). The review of scientific
literature will then be used to inform a policy critique of
Canada's asbestos policies.
Asbestos
Asbestos are fibrous, naturally occurring hydrated
silicates that have long been mined and used for their
fire-retardant and insulating properties as construction
materials (3, 4). Asbestos can be found in amphibole
and serpentine forms (5, 6).  95% of the asbestos mined
globally is in a serpentine form of chrysotile type, with
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Current risks
Adverse health effects from exposure to asbestos
remain a serious concern to miners, mining
communities and residents of buildings that contain
asbestos.  Miners and mining communities are at the
greatest risk from asbestos related diseases, but are
better prepared to limit their exposure to asbestos than
homeowners who are unknowingly breathing in
asbestos. There is a time lag of 15 to 40 years between
exposure and asbestos-caused disease for both residents
and miners, which often makes it difficult to relate
historical exposure to current symptoms  (Figure 2) (7,
3). Asbestos has far-reaching and long-lasting impacts
for human health, both through occupational and
environmental exposure.  
EXPOSURE
Pathways
Exposure to asbestos fibres occurs through ingestion,
skin contact or inhalation (3, 9, 13).  Inhalation of
asbestos fibres is dangerous and results in asbestos-
related diseases.  Skin contact with raw asbestos fibres
results in relatively harmless epidermal overgrowth.
Ingestion of water from asbestos-contaminated pipes
has not been found to increase the incidence of
asbestos-related diseases (14).  The remainder of this
essay will therefore focus exclusively on inhalation of
asbestos fibres. 
Persistence
Asbestos occurs naturally underground in trace
quantities. Amphiboles are naturally present in surface
soils in specific regions of several countries including
Finland, Greece and Afghanistan, and affect local
residents (3). However, since asbestos is only dangerous
when inhaled, subsurface deposits pose little risk.
When these deposits are mined, airborne concentrations
increase greatly In Libby, Montana, mining and
processing of asbestos-contaminated talc and
vermiculite increased airborne asbestos concentrations
from <0.004 in 1847 to 0.022 fibres/cm3 in 1995.  These
airborne concentrations become embedded in the tree
bark, where the asbestos persists and can affect those
who harvest the contaminated wood (15). Exposure to
asbestos can occur when workers process products such
as talc and vermiculite that are naturally contaminated
by tremolite (3). Asbestos-contaminated vermiculite
was mined in Libby, Montana for 70 years, leading to
infection of both workers and the community since
workers brought home materials from the mine and
used them as clean fill in constructing driveways and
gardens. Asbestos therefore persists in trace amounts in
soil and in larger concentrations in buried waste sites
(16). 
Risk
The risks associated with asbestos are significant, and
workers have historically been subjected to
concentrations 10-100 times the Canadian legal limit of
1 fibres/cm3 (3, 17, 13). These workers have suffered
from a wide range of health effects. Asbestos has a
significant risk even at lower concentrations. The
families of workers have therefore had elevated rates of
asbestos-related diseases from the asbestos
inadvertently brought home on the clothing of miners.
Radiographs of the spouses of workers exposed to
asbestos indicated that 19% of them suffered from
pleural changes, and that the only factor of significance
in detailed questionnaires was the latent period since
first exposure. The microscopic fibres of asbestos are
therefore impossible to eliminate from the indoor air
environment, and pose a significant risk for the
workers, their families and those whose homes contain
airborne asbestos.
Figure 1. Correlation of Asbestosis and Asbestos Mined from 1900-
2055 in the United States (Cudgell and Kamp, 2004)
Figure 2. Malignant mesothelioma most frequently affects the lining
of the lungs (3). Asbestos 123 Vol. 10  No. 2
CAUSES OF HEALTH PROBLEMS
Exposure to asbestos results in a variety of health
problems caused by the autoimmune, genotoxic and
irritative effects of asbestos. Within each of these
categories, case studies and experiments will be referred
to in order to illuminate differences between the
mechanisms of different types of asbestos.  
Autoimmunity
Autoimmune diseases such as rheumatoid arthritis,
systemic lupus erythematosus and multiple sclerosis
have been found at increased rates in populations
exposed to asbestos (13). An epidemiological study of
the autoimmune effects of asbestos exposure was
conducted on 7,307 residents of Libby, Montana who
had undergone occupational and environmental
exposure to amphibole asbestos  from a local
vermiculite mine (18, 13). Of these residents, 6.7%
were diagnosed with auto-immune diseases, compared
to a rate of 1% in an unexposed population in Missoula,
MT. Furthermore, elevated levels of autoantibodies
were detected in the exposed population at a rate 28.6%
higher than the general Missoula population.  However,
despite the statistical significance of these findings, the
causation between asbestos exposure and autoimmune
diseases is still incompletely explored. Asbestos is
believed to bring about systemic autoimmunity by
suppressing the body's natural killer cells, and has been
thought to increase the incidence of lung cancer by
suppressing pulmonary parenchymal cells (19, 21). A
study exposed mice to serpentine chrysolite asbestos
and amphibole crocidolite asbestos to compare the
effects of these two types of asbestos on autoimmunity.
The results from this experiment determined that
crocidolite asbestos had a slightly more toxic impact
than chrysotile on the immune function of pulmonary
parenchymal cells (20). This finding confirms the more
damaging health effects overall of amphibole asbestos
in comparison to serpentine asbestos.  
Genotoxicity 
The genotoxic effects of asbestos have been found
both in factory workers (17) and their wives (21).  In
these studies, asbestos has been found to damage DNA,
gene transcription and protein expression (17, 21).  The
resulting genotoxic effects would lead to inflammation,
cell death and errors in modulating cell proliferation (7).
Although further research is still required to identify the
mechanisms through which asbestos incites
genotoxicity, multilocus deletions of DNA in hybrid-
human cells have been induced through exposure to
crocidolite (22). Research on in vivo rats has found that
chrysotile promotes genotoxicity more rapidly than
crocidolite (23). This difference may be due to fibre
length, as indicated by an in vivo experiment by Keane
et al which found that the magnitude of asbestos-related
disease on Chinese hamster lungs grew with the length
of the fibre (24). Genotoxicity is therefore related to
length, which means that longer serpentine chrysotile
fibres are more genotoxic than short amphibole asbestos
fibres.  This finding runs counter to reviews that have
summarized the effects of amphibole asbestos as more
damaging that the effects of serpentine asbestos (4, 6).
It is possible that the genotoxic effects are either less
important or take longer to manifest than the health
effects of irritation and autoimmunity, and therefore
have not yet appeared in research literature because
earlier studies included all forms of asbestos together
(25).
Irritation 
Upon inhalation, asbestos causes significant irritation
to the lungs and bronchioles. The resulting irritation
causes the lungs to try to digest the asbestos. However,
because of its chemical and physical stability, the
asbestos cannot be digested and instead becomes
encased in scar tissue. Growing masses of scar tissue
result in benign fibrosis, effusions and plaques in the
lung cavity (12). Since crysolite fibres are thin-walled
sheets of silicates, they have a half-life of of 0.3-11
days, whereas the double-chained chemistry of
amphibole fibres have a much longer half life that
extends from 500 days to infinity (25). It is therefore
clear that amphibole fibres have a much more irritative
effect on the lungs than crysolite fibres and are therefore
much more likely to lead to asbestosis, effusions and
plaques through irritation.
RESULTING HEALTH EFFECTS
The diseases that result from the aforementioned
causes will now be analyzed, starting with the benign
effects of asbestosis, effusions and plaques, and then
moving on to bronchogenic lung cancer and malignant
mesothelioma. After describing the symptoms and
causes of each diseases, the incidence of each disease
will then be analyzed in terms of the type of asbestos
that the population was exposed to, to determine the
varying risks of various types of asbestos.
Asbestosis 
Asbestosis is a disease characterized by bilateral
interstitial pulmonary fibrosis due to the inhalation of
asbestos fibres (26, 3). The fibrosis of the lungs causes
shortness of breath and dry cough.  In severe cases,
patients have difficulty with oxygen diffusion, since the
disease primarily affects the base of the lungs (26).
Amphibole fibres have been strongly linked to
asbestosis through a series of nine epidemiological124 McGill Journal of Medicine 2007
studies reviewed by Hessel et al (27).  However,
chrysotile fibres break apart so quickly that they result
in no fibrosis at subchronic levels (3413 total
fibres/cm3) (25). Asbestosis is therefore contracted
primarily through amphibole fibres.
Plaques
Pleural plaques occur when fibrosis is localized in a
specific region of the lung. Plaques are a distinctive
feature of asbestos exposure that cause functional
impairment (28, 3). However, whereas Goldsmith
found plaques to be benign (28), Sprince et al have
linked the presence of plaques with the emergence of
cancer and immune deficiency (5). It seems likely that
disagreements over the prognosis of plaques in terms of
their propensity towards malignancy may be better
resolved with a more thorough look at the differences in
the rates of malignancy caused by the two main forms
of asbestos. With this in mind, we will now turn to
examine the two carcinogenic diseases caused by
asbestos.  
Malignant mesothelioma 
Malignant mesothelioma is a type of cancer caused
by asbestos that occurs in the lining of the lungs or the
abdomen (Figure 2) (3).  In a mortality study of Prieska,
a South African town that had been milled and mined
extensively for asbestos, it was found that the risk of
death by malignant mesothelioma was 277/106 (29).
The current incidence of malignant mesothelioma is
projected to double in Europe over the next 20 years
due to increased knowledge about this disease, which is
often missed or misdiagnosed as pneumonia (30).
Rates of malignant mesothelioma are much greater
when populations have undergone exposure to
amphibole fibres, because of the greater persistence of
amphibole fibres, and their greater autoimmune effect
(31).  McDonald et al. (32) have shown through an
epidemiological study of asbestos workers in Quebec
that the diminished rates of malignant mesothelioma
associated with serpentine asbestos were also due to the
lower concentrations of fibrous tremolite, an asbestos
mineral with significant pathology.
Bronchogenic lung cancer
Bronchogenic lung cancer is brought about through
interstitial pulmonary fibrosis, which then becomes
malignant when the body's autoimmune defenses break
down (3). An epidemiological study of a town in Turkey
with natural deposits of asbestiform minerals found
elevated rates of bronchogenic lung cancer.  Upon
autopsy of a patient who died from lung cancer, many
asbestos bodies were found. They were composed of
tremolite fibres with few chrysolite fibres (33).  This
finding supports the evidence mentioned in the previous
section that amphibole asbestos is more irritative and
persistent in the lungs and has a stronger autoimmune
effect. It also supports the findings that tremolite
concentrations increase the incidence of cancer (32).
The increased irritation causes the fibrosis that results in
tumors. The breakdown of the autoimmunity in the
lungs then results in bronchogenic lung cancer.  
Effusions
Effusions occur when fluids accumulate in the lungs.
These events can be acute with complete resolution, or
can be chronic and result in significant accumulations
of fluid with associated fever and pain (3).  If severe,
effusions can result in rounded ateclatasis, where the
lung is left without air.  Effusions occur frequently
when mesothelioma sets in, but can also result from
benign fibrosis, plaques and nonspecific fibrous
thickening (34).  Effusions are therefore symptoms of
asbestos exposure that can result in death. Amphibole
fibres have been associated with effusions more so than
chrysolite fibres (34), likely because amphibole fibres
are more irritative and long-lasting in the lungs (25).  
CANADIAN POLICIES ON ASBESTOS
Despite the increased knowledge of the risks and
consequences of exposure to asbestos, Canadians
continue to be exposed to asbestos through unintended
environmental exposure, and occupational exposure at
levels of up to 1 fibre/cm3.  It is therefore vital that this
analysis of the health effects of asbestos conclude with
an analysis of current legislation for asbestos and its
implications in light of scientific evidence, as well as a
list of policy recommendations.
Current Legislation
The Canadian Government currently prohibits the
spraying of mixtures of fibres that contain asbestos if
the fibres are not fully encapsulated during spraying in
Item 40 in Part 1 of Schedule 1 to the Hazardous
Products Act (HPA) (35). Products containing
crocidolite asbestos fibres are banned, but an exemption
in 12(f) of the HPA states that these products are not
banned if they are "packaged as a consumer product"
(35). Finally, Item 37 in Part 1 of Schedule 1 of the HPA
bans the advertising, sale and importing of all products
that consist in their entirety of asbestos fibre. The
background to this section of the HPA reads:
the addition of this item to the Schedule does not affect the
commerce of products that contain asbestos as an ingredient
(irrespective of the concentration of asbestos) nor the
sale/importation of pure asbestos to/by industrial users (35) 
The ban is therefore so narrow as to have little effect on
community-level exposure to asbestos.Asbestos 125 Vol. 10  No. 2
Canada also continues to export chrysotile to the EU
despite their ban under the justification that "Canada
considers that the bans imposed by many EU Member
States and the Commission cannot be justified by
scientific risk assessments" (36).  Meanwhile, a wealth
of scientific evidence referred to previously in this
review has demonstrated that evidence directly links
chrysotile asbestos with health risks.
Workers who process chrysotile or have been
exposed to asbestos for over 2,000 hours in their
lifetime must undergo a mandatory chest x-ray (37).
However, the implications of this regulation regarding
compensation and health care are unclear when a
problem is detected.  
Implications
The laxness of the regulations concerning the sale,
export and mining of asbestos has detrimental
consequences for the health of Canadian communities.
The Chrysotile Institute continues to receive federal
subsidies to mine asbestos in Quebec, and sets safety
regulations "in accordance with government" in Canada
(1). The safety regulations developed were described in
the previous section, and since these regulations protect
corporate interests more than community health, there
are serious implications for community health.
Since asbestos-related diseases appear many years
after first exposure to asbestos (Figure 3), it is often
difficult to establish a link between disease and
exposure, especially since smoking and genetics are
confounding factors in the incidence of asbestos-related
diseases. Lawyers and corporations have therefore
depended on scientists to prove or disprove this link.
Miller (2006) found in his analysis of radiographic
readings for asbestosis using International Labour
Office classification that evidence has been misused by
the media and attorneys to give undue compensation to
victims.  However, evidence has also been found that
victims of asbestos exposure are often misdiagnosed,
and fail to receive adequate protection (4).  The lack of
firm government guidelines for the use and mining of
asbestos is therefore of great detriment to miners and
their communities.  
Recommendations
Since epidemiological analyses and animal testing
have clearly shown that asbestos has health effects
through occupational and environmental exposure, it is
the responsibility of the government to protect the
health of its citizens instead of yielding to economic
corporate interests. The government of Canada must
stop exporting asbestos to EU countries in which
asbestos has been banned, instead of continuing to
challenge the rights of these countries to refuse imports
using WTO guidelines (36). Although chrysotile is less
potent than other forms of asbestos, serious questions
must be asked about whether the benefits of economic
development in Quebec outweigh the long-term health
consequences of exposure to asbestos.  One potential
way in which these costs and benefits can be better
balanced is by forcing companies such as the Chrysotile
Institute to assume responsibility for the compensation
of people affected by asbestos.  
Overall, better monitoring is required, both of the
health of miners and their communities and of indoor air
quality in buildings containing asbestos.  Despite claims
that indoor air quality testing of public buildings is
unnecessary and unduly frightens the population, the
overwhelming risks of exposure and subsequent health
effects warrant testing these sites for indoor air quality.
It is only through a thorough knowledge of the potential
health effects of a specific site that informed policies
can be created.
The purpose of this paper has been to review current
scientific literature on the risks and health effects of
exposure to different types of asbestos, and then use this
scientific evidence to critically analyze current
Canadian policies. The main problem in the existing
policies is that they are not based on scientific evidence
of the health effects of asbestos, and are designed not to
mitigate these effects, but to create an appearance of
maintaining public health standards while yielding to
corporate interests. The continuing health consequences
of asbestos are therefore a prime example of the way in
which policymakers are choosing short-term economic
benefits instead of minimizing scientifically established
risks, to the great detriment of our communities. 
Figure 3. Delay between the time of first exposure and employee
diagnosis with asbestos-related diseases (Kamp and Weitzman, 1999)126 McGill Journal of Medicine 2007
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